Mass Defect Filter for Metabolite Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The detection and identification of drug metabolites and impurities/degradants in biological samples and drug formulations are challenging due to interference from endogenous species and polymeric excipients, which complicates mass spectra and makes it difficult to accurately detect target ions, especially at low concentrations or with unknown molecular identities.
Innovation Solution
A mass defect filter is used in high-resolution mass spectrometry analysis to selectively retain ions within a specified mass defect range, discarding interference ions and enhancing the detection and identification of drug metabolites and impurities/degradants by differentiating between isobaric ions and filtering out polymeric interferences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If high resolution mass spectrometry is used to detect metabolites and impurities, then detection sensitivity is improved, but interference from endogenous species and polymeric excipients increases
Solution Approach 1:
The patent applies mass defect filtering by changing the parameter of mass-to-charge ratio selection. Instead of detecting all ions within a mass range, the system filters ions based on their mass defect values (the difference between actual mass and nominal mass). This parameter-based filtering allows selective retention of drug-related ions while excluding endogenous species and polymeric excipients that have different mass defect characteristics, thus resolving the contradiction between detection sensitivity and interference rejection.
2Productivity
If mass spectrum analysis is performed on samples with polymeric excipients, then comprehensive detection is achieved, but signal complexity increases making target identification difficult
Solution Approach 1:
The patent extracts useful information from complex mass spectra by applying mass defect filtering. The system separates drug-related ions from the complex background of polymeric excipient ions based on their distinct mass defect characteristics. This extraction process removes irrelevant signals while retaining target ion signals, thereby reducing signal complexity while maintaining comprehensive detection capability for metabolites and impurities.
3Object-generated harmful factors
If background subtraction techniques are used to reduce interference, then some background noise is removed, but selectivity for low concentration metabolites and impurities remains insufficient
Solution Approach 1:
The patent improves upon background subtraction by changing from intensity-based subtraction to mass defect-based filtering. Instead of simply subtracting background intensity, the system uses the specific mass defect parameter to identify and retain drug-related ions. This parameter-based approach provides superior selectivity for low concentration metabolites and impurities because it targets ions based on their intrinsic mass characteristics rather than just their intensity profile, effectively distinguishing target ions from background noise even at trace levels.
Data Source
AI summary
A method for detecting and identifying metabolites in biological samples includes subjecting the samples to high resolution mass spectrometry (MS) analysis to detect ions of the molecular species. Mass defect values for the detected ions are determined. The method also includes specifying a predetermined range for mass defect values. Detected ions having mass defect values falling outside the specified range are discarded and those with mass defect values falling within the predetermined range are retained. Species of interest are determined from the retained values. The species of interest include drug metabolites or impurities and/or degradants of a known pharmaceutical sample.